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ABSTRACT
Introduction: Fallopian tube damage and subsequent infertility are common sequelae of upper geni-
tal tract infection with Chlamydia trachomatis. This fallopian tube damage is thought to be immune
mediated. The 60 kilodalton chlamydial heat shock protein (hsp) may be the key antigen associated
with this pathogenic response. Our objective was to study the relationship between antibody re-
sponse to 60 kilodalton chlamydial hsp and tubal factor infertility (TFI).
Subjects and Methods: Twenty-three women with TFI and 33 women with male factor infertility
(controls) were studied. Tubal factor infertility was defined as infertility for one year with hydro-
salpinx or distal tubal occlusion. Patients’ sera were tested for antibodies to the chlamydial hsp
using an enzyme-linked immunosorbent assay (ELISA). A stepwise logistic regression was per-
formed by each patient’s age, race/ethnicity, self-reported history ofchlamydia infection, gonorrhea,
or pelvic inflammatory disease (PID), history of ectopic pregnancy, and antibodies to the chlamyd-
ial hsp.
Results: Eighteen of the 23 women with TFI had a positive result on the hsp ELISA (78.6%)
versus 23.4% of controls. Risk factors for TFI were a history ofPID (P 0.022), "nonwhite" race
(P 0.004), history of ectopic pregnancy (P 0.027), and antibodies to the 60 kilodalton chlamydial
hsp (P < 0.001).
Conclusions: Antibodies to 60 kilodalton chlamydial hsp are strongly associated with TFI. Infect.
Dis. Obstet. Gynecol. 6:163-167, 1998. (C) 1998 Wiley-Liss, Inc.
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hplamydia
trachomatis is the most commonly re-
orted bacterial infection in the United States.
As a sexually transmitted pathogen, chlamydia can
ascend through the female reproductive tract and
cause fallopian tube damage. One of the important
sequelae of this damage is infertility. Fallopian
tube damage is responsible for 36% of cases of fe-
male infertility, z It is estimated that 75,000 to
225,000 women become infertile every year in the
United States as a result of infection. A history of
pelvic infection is the most important risk factor for
tubal factor infertility (TFI). The likelihood of in-
fertility increases with increased number of epi-
sodes of pelvic inflammatory disease (PID), as well
as increased severity of these episodes.3 Despite
this link between infections and infertility, clinical
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predictors for TFI are lacking. Most women with
TFI do not give a history of prior infection. In one
study, women with TFI but without a history of
PID were similar to fertile controls in regards to
marital status, education, socioeconomic status, and
total number of sexual partners.
4
Recent research has suggested that antibodies to
the 60 kilodalton chlamydial heat shock protein
(hsp) are associated with TFI. This antigen is a
member of the family of "stress" or "heat shock"
proteins, a group of highly conserved membrane
proteins found in both prokaryotes and eukaryotes.
In cell culture models, increased expression of 60
kilodalton chlamydial hsp is associated with arrest
of the chlamydial developmental cycle and persis-
tence of infection,s Using chlamydial hsp as the
antigen in an enzyme-linked immunosorbent assay
(ELISA), Toye et al.6 found a detectable antibody
response in 32 of 44 (81%) women with TFI. Like-
wise, Arno et al. 7 reported that 16 of 21 (76%)
women with TFI had antibodies to this protein. It
is our hypothesis that this antibody response to 60
kilodalton chlamydial hsp can be correlated to TFI.
We report here a study incorporating other demo-
graphic variables that are potentially associated
with fallopian tube damage.
SUBJECTS AND METHODS
Women attending the Women’s Reproductive
Center at the University of Kansas Medical Center
between 1994 and 1996 were eligible for this study.
This facility offers a full range of infertility ser-
vices, including laboratory services and assisted re-
productive technologies. Eligible patients were
identified by a review of patient charts and labora-
tory records. Demographic variables were ab-
stracted at the time of chart review. All women in
this study had at least a basic infertility evaluation.
This evaluation included a test for tubal patency
(hysterosalpingogram and/or laparoscopy), a test of
the male partner (semen analysis), and a test for
ovulation (basal body temperature chart and/or
midluteal progesterone level).
Women were considered to have TFI if they
were having regular unprotected intercourse with-
out conception for one year with evidence of distal
obstruction, pelvic adhesions, or hydrosalpinx on
hysterosalpingogram or laparoscopy. Women were
excluded from this group if any other cause of in-
fertility was found, such as endometriosis, abnor-
malities in semen analysis, anovulation, or luteal
phase defect. Control patients were selected from
the same population. Women were eligible to be
controls if they were having regular unprotected
intercourse without conception for one year with
demonstrated tubal patency on laparoscopy or hys-
terosalpingogram. Additionally, these women had a
diagnosis of male factor infertility as demonstrated
by an abnormal semen analysis. Abnormal semen
analysis was defined according to World Health Or-
ganization criteria.8 Likewise, women were ex-
cluded as controls if any other reason for infertility
was identified as stated above. All subjects and
controls were tested for infection with C. trachoma-
tis with endocervical culture, and no patient in ei-
ther group was positive.
Antibodies to 60 kilodalton chlamydial hsp were
measured by ELISA. Procedures for purifying this
protein using an immunoaffinity column have been
previously described.9 Ninety-six well microtiter
plates (Immunlon 2, Dynatech, Chantilly, VA)
were coated with 100 pL of pg/mL solution of
chlamydial hsp in phosphate buffered saline and
adsorbed three hours at 37C. Plates were washed
three times with phosphate buffered saline then
blocked with 150 pL of 3% bovine serum albumin
in phosphate buffered saline per well for 90 min-
utes at 37C. One hundred microliters of patients’
sera (diluted 1:500 in phosphate buffered saline
containing 0.1% bovine serum albumin and 0.2%
TWEEN 20) were then added to duplicate wells
and incubated for 60 minutes at 37C. After three
additional washes with phosphate buffered saline,
100 pL of a 1:5000 dilution of alkaline phospha-
tase-conjugated rabbit anti-human IgG (Jackson
Immunoresearch Laboratories, West Grove, PA)
was then added to each well and incubated for 30
minutes at 37C. After rinsing three times with
phosphate buffered saline containing 0.2%
TWEEN, 100 pL of p-nitrophenol phosphate in
diethanolaminc solution (Sigma, St. Louis, MO)
were added to each well and the plates were incu-
bated for 30 minutes at 37C. Absorbance was then
read at 405 nm using an automated plate reader.
(ThcrmoMax, Molecular Devices Corporation,
Menlo Park, CA)
Sera from 28 pregnant women were used to de-
fine cut-off values as previously described.6 These
pregnant women all tested negative for antibodies
to C. trachomatis serovar L2 elementary bodies us-
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ing a commercially available ELISA (Clark Labo-
ratories, Jamestown, NY). None gave a history of
prior infection with C. trachomatis, and none had
infectious complications with their pregnancies.
The mean absorbance of these 28 seronegative
samples plus three standard deviations was consid-
ered the cut-off value for negative values in the
chlamydial 60 kilodalton hsp ELISA. This value
was 0.218, and values above this were considered to
be positive for antibodies to the chlamydial hsp.
Two positive control samples from previously pub-
lished studies were also used. Tolerance for intra-
assay or interassay variance was 10% or less.
The following variables were considered for our
multivariate analysis: age greater than 35 years,
race/ethnicity (white versus "nonwhite"), a self-
reported history of chlamydia infection, a self-
reported history of PID, a self-reported history of
any infertility-related infection (gonorrhea, chla-
mydia, or PID), a history of ectopic pregnancy, and
results of chlamydial 60 kilodalton hsp ELISA. An
initial analysis was done with chi-square tests and
variables found to be associated with TFI were
used in a stepwise logistic regression. Odds ratios
and P values were calculated using the permuta-
tion-based logistic regression algorithms of LogX-
act-Turbo version 1.3 (Cambridge, MA). The hu-
man subjects committee of the University of Kan-
sas Medical Center approved this protocol.
RESULTS
Twenty-three women with TFI as the sole cause of
their infertility were identified. Likewise, 33
women with male factor infertility were identified
as controls. Eighteen of the 23 women with TFI
(78.6%) were positive for antibodies to the chla-
mydial hsp. Selected variables for subjects and con-
trois are shown in Table 1.
Results of the stepwisc logistic regression are
shown in Table 2. Age and a self-reported history
of infertility-related infection were not significant
in the models that were considered. As shown in
the table, the following variables were significantly
associated with TFI: history of PID (adjusted odds
ratio 28.8, P 0.022), history of ectopic pregnancy
(adjusted odds ratio 16.8, P 0.027), nonwhite race
(adjusted odds ratio 57, P 0.004), and antibodies
to 60 kilodalton chlamydial hsp (adjusted odds ratio
30.6, P < 0.001).
TABLE I. Selected demographic variables for
subjects and controls
Subjects Controls P
Variable (n 23) (n 33) value
History of ectopic
pregnancy
History of PID
History of chlamydia
infection
History of PID,
gonorrhea, or
chlamydia
Nonwhite race
Age >35 y
Positive for antibodies to
the chlamydial heat
shock protein
8/23 (34.8%) /33 (3.0%)
6/23 (26. I%) 0/33 (0%)
3/23 (13.0%) 1/33 (3.0%)
9/23 (39.1%) !/33 (3.0%)
7/23 (30.4%) 0/33 (0%)
8/23 (34.8%) 8/33 (24.3%)
0.002
0.003
NS
<0.001
0.001
NS
18/23 (78.3%) 8/33 (24.3%) <0.001
aSignificance was calculated by chi-square test.
bNS, not significant.
CONCLUSIONS
Antibodies to chlamydial 60 kilodalton hsp are
strongly associated with TFI. As reported in two
previous studies, a large majority of women with
TFI have antibodies to this antigen. The differ-
ence between this study and previous studies is
that we carefully defined a control group and ex-
amined confounding factors associated with TFI.
Most serological studies involving human re-
sponses to chlamydia have not included well-
defined control groups. The association between
hsp 60 antibodies and TFI remained when other
confounding variables were included in a multivari-
ate analysis. It is the only risk factor present in a
majority of women with TFI.
Other factors associated with TFI are consistent
with previous studies. A history of PID was also a
predictor ofTFI in this study. As stated previously,
this is the risk factor most consistently associated
with TFI.3 However, a majority of women with
TFI in this study (17 of 23 women, or 74%) did not
report PID. In a larger multicenter trial, 84% of
women with TFI do not give a history of PID.4
Also similar to previous studies, nonwhite race was
associated with TFI. This is likely due to increased
rates of sexually transmitted diseases among mi-
norities.3 Ectopic pregnancy due to fallopian tube
damage presumably shares a common pathogenesis
with TFI, hence the finding that a history of ecto-
pie pregnancy predicts an increased risk of TFI. In
one large multicenter case-control study from
France, predictors of ectopic pregnancy include a
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TABLE 2. Results of multivariate analysis
Variable Unadjusted odds ratio Adjusted odds ratio 95% confidence interval Significance
Hsp 60 Antibodies
Nonwhite race
History of ectopic pregnancy
History of PID
10.6 30.6 4.3 to infinity 0.000
18.6 57 3.8 to infinity 0.0037
16.2 16.8 1.36 to infinity 0.027
14.6 28.8 1.59 to infinity 0.022
aSignificance was calculated by permutation based, stepwise logistic regression algorithm.
history of symptomatic sexually transmitted dis-
ease, history of PID, serological evidence of prior
infection with chlamydia, and a recent partner with
urethritis. 11 Unlike previous studies, age was not
associated with an increased risk of TFI. Also un-
like previous studies, a history of sexually transmit-
ted diseases was not associated with TFI. Grod-
stein et al. lz showed that women with TFI more
commonly report a history of gonorrhea. Along with
chlamydia, gonorrhea is known to be an upper
genital tract pathogen capable of causing tubal
damage and infertility. This lack of an association
between TFI and a self-reported history of gonor-
rhea might reflect the national trend in the preva-
lence of gonorrhea: the number of cases of gonor-
rhea in the United States has steadily decreased
since 1975.13 There were 266,507 cases of gonor-
rhea in women reported to the Centers for Disease
Control and Prevention in 1991, and 188,650 were
reported in 1995, a 29% decrease. Only one patient
in the study reported a history of gonorrhea, and
she was in the subject group.
This study does not address the pathogenic
mechanisms by which an immune response to 60
kilodalton chlamydial hsp causes TFI. This is an
active area of research and at least three theories
have been put forward. Morrison et al. 14 explained
the pathogenic response to chlamydia based on dif-
ferences between the Thl and Th2 lymphocyte
subsets. According to this hypothesis, protective
responses are driven by a Th2 response. Th2 lym-
phocytes would stimulate the production of anti-
bodies, and these antibodies would provide a local-
ized mucosal defense against attachment of the
chlamydial elementary body to the tubal epithe-
lium. Thl cells stimulate macrophages and cell-
meditated immunity. If the hsp is the antigenic
stimulus for a Thl response, activated macro-
phages and pro-inflammatory cytokines could lead
to immune-mediated fallopian tube damage. Wit-
kin is has proposed a theory based on the homology
between human and chlamydial hsp. Heat shock
proteins are highly conserved across species. Ac-
cording to this hypothesis, sensitized lymphocytes
develop to hsp 60. These lymphocytes would then
cross react with shared epitopes of the human hsp
and lead to autoimmune destruction of the fallo-
pian tube. Recently, Kimani et al. 16 reported that
antibodies to chlamydial 60 kilodalton hsp are a
risk factor for the development of PID due to C.
trachomatis. Based on their analysis of HLA types,
they suggest that CD8 cytotoxic lymphocytes spe-
cific for chlamydial hsp lead to damage. These
lymphocytes would lyse infected fallopian tube ep-
ithelial cells as the pathogenic mechanism.
In summary, antibodies to the 60 kilodalton
chlamydial hsp are strongly associated with TFI in
this study from a single institution. Further re-
search should concentrate on the role this antigen
plays in the immunopathogenesis of fallopian tube
damage. Additionally, testing for this antibody re-
sponse may be a clinically useful test for the evalu-
ation of the infertile woman.
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